Five out of 41 patients ( with no prior history of hepatitis B vaccination) had anti-HBs titre >10 mIU/ml because of the prior HBV infection (evidenced by reactive anti-HBc, as described later). Here, KRT88P is linked to hepatitis B virus infection.